E
ExoGenis provides a dissolvable microneedle patch system for the non-injectable delivery of fragile biologics into viable skin layers. This technology bridges the gap between superficial topicals and invasive injections for aesthetic and dermatology clinics. The system ensures controlled placement and preserves biologic activity for maintenance treatments between procedures.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Exogenis develops a non-injectable microneedle delivery system for placing fragile biologics beyond the skin surface. This technology bypasses the limitations of topical application by effectively delivering extracellular vesicles, growth factors, and peptides into deeper skin layers. The system bridges topical and injectable approaches, initially targeting professional cosmetic and aesthetic applications with future clinical compatibility.